Alyeska Investment Group
IPXL

Alyeska Investment Group’s Impax Laboratories, Inc. IPXL Stock Holding History

Alyeska Investment Group’s Portfolio IPXL Stock Details IPXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-1,125,047
Closed -$18.7M – 563
2017
Q4 		$18.7M Buy
1,125,047
+658,532
+141% +$12.1M 0.15% 168
2017
Q3 		$9.47M Buy
+466,515
New +$8.92M 0.07% 247
2016
Q4 		– Sell
-1,061,001
Closed -$25.1M – 603
2016
Q3 		$25.1M Sell
1,061,001
-464,504
-30% -$12.5M 0.23% 152
2016
Q2 		$44M Buy
1,525,505
+306,431
+25% +$9.99M 0.41% 90
2016
Q1 		$39M Sell
1,219,074
-1,479
-0.1% -$52K 0.36% 100
2015
Q4 		$52.2M Buy
1,220,553
+466,464
+62% +$18.6M 0.55% 61
2015
Q3 		$26.6M Buy
+754,089
New +$34M 0.31% 127

Other funds holding IPXL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
TG
TCW Group Los Angeles, California $14.9B AUM 46.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Alyeska Investment Group's IPXL Position: Q1 2018 in Review

Alyeska Investment Group sold out of Impax Laboratories, Inc. (IPXL) in Q1 2018, closing a stake of 1,125,047 shares — an estimated $18.7M sold.

Alyeska Investment Group first reported a position in IPXL in Q3 2015 and held it in 7 quarters. The position peaked at $52.2M in Q4 2015. 188 funds tracked by Wall St. Rank hold IPXL as of Q1 2018.

  • Alyeska Investment Group reported no remaining Impax Laboratories, Inc. position as of Q1 2018 after selling out during the quarter.
  • Alyeska Investment Group sold 1,125,047 Impax Laboratories, Inc. shares in Q1 2018, an estimated $18.7M.
  • Alyeska Investment Group first reported a position in Impax Laboratories, Inc. in Q3 2015 and held it in 7 quarters.
  • Alyeska Investment Group's Impax Laboratories, Inc. position peaked at $52.2M in Q4 2015.
  • 188 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q1 2018.

Based on Alyeska Investment Group's 13F filing for Q1 2018, filed 15 May 2018.